MAPT and Cognitive impairment: Therefore, there is a compelling case for incorporating synaptic biomarkers into the routine cerebrospinal fluid (CSF) assessment of cognitive impairment, alongside Aβ42/40, phosphorylated tau (p‐tau), and total tau (t‐tau).